Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Alderaan Biotechnology

Alderaan Biotechnology

Series A
Paris, FranceFounded 2017Jan 2020
Healthtech

Alderaan Biotechnology raised €19M in a Series A round in Jan 2020. The company is based in Paris, France. Investors in the round: Advent France Biotechnology (AFB) and Medicxi. Data as of Nov 2026.

← Alderaan Biotechnology
Amount raised
€19M
€18,500,000
Native amount
18,500,000 EUR
Stage
Series A
series a
Investors
1

Provenance & confidence

High confidence
Amount

Reported in EUR — no conversion. €19M

High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Advent France Biotechnology (AFB) and Medicxi
Date
Jan 2020
Round type
series a
Amount (EUR)
€19M

Other rounds

same company

This is the company's only recorded round.

Related news